Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Alabama at Birmingham
Aurigene Discovery Technologies Limited
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Virginia
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
M.D. Anderson Cancer Center
Ono Pharmaceutical Co., Ltd.
Prelude Therapeutics